| Name | brd9757 |
|---|
| Description | BRD9757 is a potent, capless and selective HDAC6 inhibitor with an IC50 of 30 nM. BRD9757 shows excellent selectivity toward HDAC6 versus the class I (>20-fold) and class II (>400-fold) HDACs[1]. |
|---|---|
| Related Catalog | |
| Target |
HDAC6:0.03 μM (IC50) HDAC1:0.638 μM (IC50) HDAC2:1.79 μM (IC50) HDAC3:0.694 μM (IC50) HDAC4:21.80 μM (IC50) HDAC5:18.32 μM (IC50) HDAC7:12.61 μM (IC50) HDAC8:1.09 μM (IC50) HDAC9:>33.33 μM (IC50) |
| In Vitro | BRD9757(化合物 14)对抗 HDAC1、HDAC2、HDAC3、HDAC4、HDAC5、HDAC7、HDAC8 和 HDAC9,IC50 值分别为 0.638 μM、1.79 μM、0.694 μM、21.80 μM、18.32 μM、12.61 μM、1.09 μM 和 >33.33 μM[1]。 BRD9757(化合物 14;10-30 μM;24 小时)选择性地增加 Ac-tubulin 的水平,而不增加组蛋白乙酰化[1]。 Western Blot Analysis[1] Cell Line: HeLa cells Concentration: 10 μM and 30 μM Incubation Time: for 24 h Result: Increased the level of Ac-tubulin. |
| References |
| Molecular Formula | C6H9NO2 |
|---|---|
| Molecular Weight | 127.14100 |
| Exact Mass | 127.06300 |
| PSA | 49.33000 |
| LogP | 0.99300 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H319-H412 |
| Precautionary Statements | P273-P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |